CN Patent

CN103159636A — 氨甲基己酸衍生物和用途

Assigned to Individual · Expires 2013-06-19 · 13y expired

What this patent protects

本发明公开了氨甲基己酸衍生物和用途，具体地说，本发明公开了一种组合物，其包含以下式I化合物，以及作为杂质的以下式II化合物。本发明还公开了包含所述组合物制备成的药物制剂以及它们的制药用途。本发明组合物具有良好的药学性质。

USPTO Abstract

本发明公开了氨甲基己酸衍生物和用途，具体地说，本发明公开了一种组合物，其包含以下式I化合物，以及作为杂质的以下式II化合物。本发明还公开了包含所述组合物制备成的药物制剂以及它们的制药用途。本发明组合物具有良好的药学性质。

Drugs covered by this patent

Mifeprex (MIFEPRISTONE) · Corcept Therap

Patent Metadata

Patent number: CN103159636A
Jurisdiction: CN
Classification: —
Expires: 2013-06-19
Drug substance claim: No
Drug product claim: No
Assignee: Individual
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.